GRDX
Price
$4.60
Change
-$0.26 (-5.35%)
Updated
Jun 23, 04:57 PM (EDT)
Capitalization
30.95M
Intraday BUY SELL Signals
IMMP
Price
$0.39
Change
+$0.01 (+2.63%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
53.66M
71 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

GRDX vs IMMP

GRDX vs IMMP Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
GRDX vs. IMMP commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GRDX is a Hold and IMMP is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (GRDX: $4.89 vs. IMMP: $0.38)
Brand notoriety: GRDX and IMMP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GRDX: 119% vs. IMMP: 24%
Market capitalization -- GRDX: $32.55M vs. IMMP: $53.66M
GRDX [@Biotechnology] is valued at $32.55M. IMMP’s [@Biotechnology] market capitalization is $53.66M. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GRDX’s FA Score shows that 0 FA rating(s) are green whileIMMP’s FA Score has 1 green FA rating(s).

  • GRDX’s FA Score: 0 green, 5 red.
  • IMMP’s FA Score: 1 green, 4 red.
According to our system of comparison, GRDX is a better buy in the long-term than IMMP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GRDX’s TA Score shows that 4 TA indicator(s) are bullish while IMMP’s TA Score has 6 bullish TA indicator(s).

  • GRDX’s TA Score: 4 bullish, 5 bearish.
  • IMMP’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, IMMP is a better buy in the short-term than GRDX.

Price Growth

GRDX (@Biotechnology) experienced а +0.51% price change this week, while IMMP (@Biotechnology) price change was +1.86% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

Reported Earning Dates

IMMP is expected to report earnings on Sep 02, 2026.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMMP($53.7M) has a higher market cap than GRDX($31M). GRDX YTD gains are higher at: 4.828 vs. IMMP (-86.811). GRDX has higher annual earnings (EBITDA): -8.22M vs. IMMP (-43.83M). IMMP has more cash in the bank: 159M vs. GRDX (386K). IMMP has less debt than GRDX: IMMP (1.69M) vs GRDX (2.59M). GRDX has higher revenues than IMMP: GRDX (74.5K) vs IMMP (0).
GRDXIMMPGRDX / IMMP
Capitalization31M53.7M58%
EBITDA-8.22M-43.83M19%
Gain YTD4.828-86.811-6%
P/E RatioN/AN/A-
Revenue74.5K0-
Total Cash386K159M0%
Total Debt2.59M1.69M154%
FUNDAMENTALS RATINGS
GRDX vs IMMP: Fundamental Ratings
GRDX
IMMP
OUTLOOK RATING
1..100
904
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
16
Undervalued
PROFIT vs RISK RATING
1..100
72100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
3491
P/E GROWTH RATING
1..100
84100
SEASONALITY SCORE
1..100
9075

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMMP's Valuation (16) in the Biotechnology industry is in the same range as GRDX (40) in the null industry. This means that IMMP’s stock grew similarly to GRDX’s over the last 12 months.

GRDX's Profit vs Risk Rating (72) in the null industry is in the same range as IMMP (100) in the Biotechnology industry. This means that GRDX’s stock grew similarly to IMMP’s over the last 12 months.

IMMP's SMR Rating (98) in the Biotechnology industry is in the same range as GRDX (99) in the null industry. This means that IMMP’s stock grew similarly to GRDX’s over the last 12 months.

GRDX's Price Growth Rating (34) in the null industry is somewhat better than the same rating for IMMP (91) in the Biotechnology industry. This means that GRDX’s stock grew somewhat faster than IMMP’s over the last 12 months.

GRDX's P/E Growth Rating (84) in the null industry is in the same range as IMMP (100) in the Biotechnology industry. This means that GRDX’s stock grew similarly to IMMP’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GRDXIMMP
RSI
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
89%
Bearish Trend 2 days ago
77%
Advances
ODDS (%)
Bullish Trend 19 days ago
85%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 9 days ago
90%
Bearish Trend 16 days ago
83%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
84%
Aroon
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
75%
View a ticker or compare two or three
Interact to see
Advertisement
GRDX
Daily Signal:
Gain/Loss:
IMMP
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DASCX22.59N/A
N/A
Dean Small Cap Value
SVPSX103.13N/A
N/A
ProFunds Small Cap Value Svc
VRTTX638.70N/A
N/A
Vanguard Russell 3000 Index I
MXMDX24.26N/A
N/A
Empower S&P Mid Cap 400® Index Inv
AAERX19.76N/A
N/A
American Beacon International Eq R6

GRDX and

Correlation & Price change

A.I.dvisor indicates that over the last year, GRDX has been loosely correlated with DCOY. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if GRDX jumps, then DCOY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GRDX
1D Price
Change %
GRDX100%
-9.54%
DCOY - GRDX
61%
Loosely correlated
+3.79%
IVVD - GRDX
60%
Loosely correlated
-5.57%
RLMD - GRDX
35%
Loosely correlated
+2.38%
CABA - GRDX
31%
Poorly correlated
+5.63%
IMMP - GRDX
29%
Poorly correlated
+0.80%
More